Coronavirus and your health

Learn more about COVID-19 and diabetes.   |   Precautions for patients facing higher risks

Management of Risk Factors in Patients with CVD and T2D

Management of Risk Factors in Patients with CVD and T2D

Numerous studies have shown the efficacy of controlling individual cardiovascular risk factors in preventing or slowing ASCVD in people with diabetes. The American Heart Association, the American Diabetes Association and The American Society For Preventive Cardiology have partnered together to discuss Management of Risk Factors in Patients with Cardiovascular Disease and Type 2 Diabetes.

Date: Monday, December 7, 2020
Time: 5:00 pm – 6:00 pm ET

Harold Bays MD, FOMA, FTOS, FACC, FACE, FNLA, FASPC is Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center, Inc

Jane Reusch MD is Professor of Medicine, Associate Director Center of Women’s Health Research, CCTSI Studio Program Director.

Harold Bays MD Management of Risk Factors in Patients with CVD and T2D

Harold Bays MD

Jane Reusch MD Management of Risk Factors in Patients with CVD and T2D

Jane Reusch MD